The Regulatory Maze: FDI Screening Adds 4-6 Months to Cross-Border Deal Timelines
bIAnk AI Research · January 2026 · 7 min
Foreign Direct Investment screening mechanisms have expanded to 35 countries, adding 4-6 months to cross-border deal timelines and fundamentally altering execution strategies.
Foreign Direct Investment screening has expanded dramatically, with 35 countries now operating formal review mechanisms—up from just 14 in 2018. This regulatory proliferation is fundamentally changing how cross-border deals are planned and executed.
The US CFIUS regime has broadened its scope to include biotechnology, AI, quantum computing, and critical infrastructure. Review timelines have extended to an average of 6 months, with some cases taking over a year. The EU Foreign Subsidies Regulation adds another layer of review for deals involving non-EU government support.
For dealmakers, regulatory strategy must begin at the term sheet stage. Reverse break fees, regulatory condition precedents, and timeline covenants have become essential deal protections as the risk of regulatory delay or prohibition has materially increased.
Multi-jurisdictional deals face compounding challenges. A single transaction may require clearance from CFIUS, the EU Commission, UK CMA, Australian FIRB, and multiple national screening bodies, creating a complex web of parallel processes.
Sophisticated acquirers are adapting. Pre-notification engagement with regulators, advance preparation of mitigation proposals, and the use of regulatory intelligence firms to assess likelihood of intervention are becoming standard practice for experienced cross-border buyers.
Key takeaways
- 35 countries now operate FDI screening, up from 14 in 2018
- Average CFIUS review timeline extended to 6 months, some cases exceeding 1 year
- Reverse break fees and regulatory covenants now essential in cross-border SPAs
- Pre-notification regulatory engagement becoming standard for sophisticated buyers